RobertLBettikerMD
Infectious Disease • Philadelphia, PAHIV/AIDS Medicine
Associate Professor, Internal Medicine, Temple University School of Medicine
Dr. Bettiker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 N Broad St
Philadelphia, PA 19140Phone+1 215-707-3807Fax+1 215-707-4414
Education & Training
Temple University HospitalFellowship, Infectious Disease, 2000 - 2002- Temple University HospitalResidency, Internal Medicine, 1997 - 2000
Georgetown University School of MedicineClass of 1997
Certifications & Licensure
PA State Medical License 1999 - 2024- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Undiagnosed Hepatitis C Infection in an Urban Hospital Start of enrollment: 2014 Jun 01
Publications & Presentations
PubMed
- 3 citationsIbalizumab.Robert L Bettiker, David E Koren, Jeffrey M Jacobson
Current Opinion in HIV and AIDS. 2018-07-01 - 174 citationsEffects of systemic nicotine on serotonin release in rat brain.Eliane B. Ribeiro, Robert L. Bettiker, Mikhail B. Bogdanov, Richard J. Wurtman
Brain Research. 1993-09-10 - 10 citationsPrevalence and characteristics of patients with undiagnosed HIV infection in an urban emergency department.Heather Clauss, Julie M. Collins, Shaden Eldakar-Hein, Brandon Palermo, Nina Gentile
AIDS Patient Care and Stds. 2011-03-31
Press Mentions
Temple University’s Plan for Mitigating COVID-19, ExplainedJuly 9th, 2020- Are Face Shields Better Than Masks for Preventing COVID-19? Doctors DebateJune 25th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
